TRAILBLAZER MERGER CORP I (TBMC) Fundamental Analysis & Valuation

NASDAQ:TBMC • US89278D1090

Current stock price

7.325 USD
-3.63 (-33.11%)
At close:
7.84 USD
+0.51 (+7.03%)
After Hours:

This TBMC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. TBMC Profitability Analysis

1.1 Basic Checks

  • In the past year TBMC has reported negative net income.
  • In the past year TBMC has reported a negative cash flow from operations.
  • The reported net income has been mixed in the past 5 years: TBMC reported negative net income in multiple years.
  • In the past 5 years TBMC reported 4 times negative operating cash flow.
TBMC Yearly Net Income VS EBIT VS OCF VS FCFTBMC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 0 -2M -4M -6M -8M

1.2 Ratios

Industry RankSector Rank
ROA -192.3%
ROE N/A
ROIC N/A
ROA(3y)-63.16%
ROA(5y)-37.9%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TBMC Yearly ROA, ROE, ROICTBMC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 0 50 -50 -100 -150

1.3 Margins

  • TBMC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TBMC Yearly Profit, Operating, Gross MarginsTBMC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. TBMC Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, TBMC has less shares outstanding
  • Compared to 1 year ago, TBMC has a worse debt to assets ratio.
TBMC Yearly Shares OutstandingTBMC Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 2M 4M 6M 8M
TBMC Yearly Total Debt VS Total AssetsTBMC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • TBMC has an Altman-Z score of -10.36. This is a bad value and indicates that TBMC is not financially healthy and even has some risk of bankruptcy.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -10.36
ROIC/WACCN/A
WACCN/A
TBMC Yearly LT Debt VS Equity VS FCFTBMC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 0.02 indicates that TBMC may have some problems paying its short term obligations.
  • TBMC has a Quick Ratio of 0.02. This is a bad value and indicates that TBMC is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
TBMC Yearly Current Assets VS Current LiabilitesTBMC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 5M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. TBMC Growth Analysis

3.1 Past

  • TBMC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11393.33%.
EPS 1Y (TTM)-11393.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1468.29%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. TBMC Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for TBMC. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TBMC Price Earnings VS Forward Price EarningsTBMC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TBMC Per share dataTBMC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -1 -2 -3 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TBMC Dividend Analysis

5.1 Amount

  • TBMC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TBMC Fundamentals: All Metrics, Ratios and Statistics

TRAILBLAZER MERGER CORP I

NASDAQ:TBMC (3/26/2026, 8:00:00 PM)

After market: 7.84 +0.51 (+7.03%)

7.325

-3.63 (-33.11%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)03-10
Earnings (Next)05-04
Inst Owners17.1%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap17.95M
Revenue(TTM)N/A
Net Income(TTM)-8.29M
AnalystsN/A
Price TargetN/A
Short Float %3.13%
Short Ratio0.5
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.59
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.04
FCFYN/A
OCF(TTM)-1.04
OCFYN/A
SpS0
BVpS-4.87
TBVpS-4.87
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -192.3%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-63.16%
ROA(5y)-37.9%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z -10.36
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11393.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1468.29%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-63.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-63.68%
OCF growth 3YN/A
OCF growth 5YN/A

TRAILBLAZER MERGER CORP I / TBMC Fundamental Analysis FAQ

What is the ChartMill fundamental rating of TRAILBLAZER MERGER CORP I (TBMC) stock?

ChartMill assigns a fundamental rating of 0 / 10 to TBMC.


What is the valuation status for TBMC stock?

ChartMill assigns a valuation rating of 0 / 10 to TRAILBLAZER MERGER CORP I (TBMC). This can be considered as Overvalued.


Can you provide the profitability details for TRAILBLAZER MERGER CORP I?

TRAILBLAZER MERGER CORP I (TBMC) has a profitability rating of 0 / 10.